HLHyun Jeong Lee

Hyun Jeong Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hyun Jeong Lee has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in Mental Health Networks Among High-Risk Suicide Groups in Korea Before and After the COVID-19 Pandemic

    by Jeong Hun Yang, Dae Hun Kang, C. Hyung Keun Park, Sang Jin Rhee, Min Ji Kim, Hyun Jeong Lee, Sang Yeol Lee, Chan-Mo Yang, Se-Hoon Shim, Jung-Joon Moon, et al.

    Yang JH, et al. J Korean Med Sci. 2026 Aug;41:e216. https://doi.org/10.3346/jkms.2026.41.e216

  • Open Access

    Impact of a 24-Week Mobile App–Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study

    by Eun-Gyeong Lee, Dong-Eun Lee, Jeongseon Kim, Jaihong Han, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Heejung Chae, Sung Hoon Sim, Keun Seok Lee, et al.

    Background: Overweight or obesity is a prognostic factor for breast cancer recurrence and breast cancer–related deaths. However, weight control is difficult for breast cancer survivors because of menopause, chemotherapy, antihormonal therapy, and psychological issues. Objective: This study aimed to develop a 24-week mobile app–based human coaching program using Noom and evaluate its efficacy in breast cancer survivors who are excessively overweight or with obesity, including those who successfully used the program. Methods: In this single-arm prospective cohort study, 130 breast cancer survivors with BMI ≥25 were enrolled and received a 24-week program, including diet-, exercise-, and psychology-based content with the trained human coach in Noom between 2019 and 2021. For a hyperactive group who joined for more than 16 weeks, we evaluated weight, BMI, lipid level, bioimpedance, and quality of life at baseline, 6-month, and 12-month follow-up. Results: Among 130 breast cancer survivors, 101 (77.7%) and 93 (71.5%) completed the 6-month and 12-month follow-ups, respectively. The mean age of all participants was 54.90 (SD 7.42) years. At baseline, the median BMI was 27.14 (IQR 25.20‐35.36) for the hyperactive group and 27.50 (IQR 25.20‐35.50) for the active and inactive group. In the hyperactive group (68/101, 67%), body weight and BMI significantly reduced (mean difference −1.97, 95% CI −2.65 to −1.26 kg; P<.01 and mean difference −0.86, 95% CI −1.15 to −0.56; P<.01, respectively) at 6 months and were maintained at 12 months without the yo-yo effect. Among the lipid panel, triglyceride levels decreased significantly (−34.13, 95% CI −58.09 to−10.17; P<.01) and were maintained at 12 months. With respect to bioimpedance components, skeletal muscle mass (kg), body fat mass (kg), percent body fat (%), waist-to-hip ratio, and visceral fat area (cm2) improved in the first 6 months. However, waist-to-hip ratio and visceral fat area increased during the next 6 months. Based on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ C30) and Breast Cancer Module (23 items), nausea or vomiting, constipation, body image, and arm and breast symptoms significantly improved during the first 6 months. Conclusions: This study demonstrated that a 24-week mobile app–based human coaching program is beneficial for controlling body weight, BMI, triglyceride, and body composition in terms of bioimpedance for breast cancer survivors who are excessively overweight or have obesity.

  • Open Access

    Cancer Patient’s Distress: Mainly about Depression and Anxiety

    by Hyun Jeong Lee

    Hyun Jeong Lee. Journal of Digestive Cancer Research 2025;13:74-81. https://doi.org/10.52927/jdcr.2025.13.1.74


  • Open Access

    Psychotropic Medications Promote Time-Dependent Reduction of Suicidal Ideation in Mood Disorder: A Prospective Cohort Study

    by Jeong Hun Yang, C Hyung Keun Park, Sang Jin Rhee, Dae Hun Kang, Min Ji Kim, Hyun Jeong Lee, Sang Yeol Lee, Se-Hoon Shim, Jung-Joon Moon, Seong-Jin Cho, et al.

    Yang JH, et al. J Korean Med Sci. 2024 Jul;39:e226. https://doi.org/10.3346/jkms.2024.39.e226


  • Open Access

    Self-Transcendence Mediates the Relationship between Early Trauma and Fatal Methods of Suicide Attempts

    by Jeong Hun Yang, Sang Jin Rhee, C. Hyung Keun Park, Min Ji Kim, Daun Shin, Jae Won Lee, Junghyun Kim, Hyeyoung Kim, Hyun Jeong Lee, Kyooseob Ha, et al.

    Yang JH, et al. J Korean Med Sci. 2021 Jan;36(5):e39. https://doi.org/10.3346/jkms.2021.36.e39


  • Open Access

    App-based CBT Program for Patients with Cancer Who Have Sleep-related Problems: A pilot study (Preprint)

    by Kyong-Mee Chung, Yung Jae Suh, Siyung Chin, Eun-Seung Yu, Hyun Jeong Lee, Jong-Heun Kim, Sang Wun Kim, Su-Jin Koh

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Cancer, as a chronic disease, develops secondary psychological and social difficulties of which one of the most common is sleep problems. Objective: The objective of this study was to develop and evaluate an app-based cognitive behavioral therapy program for cancer patients with sleep problems. Methods: Sixty participants who met the inclusion criteria were randomly assigned to the app-based cognitive behavioral therapy program (HARUToday Sleep) (N = 15), an app-based attentional control program (HARUCard Sleep) (N = 15), or a waitlist control group (N = 15). HARUToday Sleep consists of 48 sessions separated into five zones (psycho-education, behavioral activation, relaxation training, cognitive restructuring, and problem-solving). Each participant was required to complete one 10- to 15-minute session per day on weekdays for 10 weeks. In the HARUCard Sleep, participants received one card per day, which provided information about cancer, hobbies, and activities. Participants were evaluated before and after the completion of the program using self-report questionnaires and a dot-probe computer task that measured attentional bias. Results: The intensity of sleep problems decreased significantly after the intervention for the HARUToday Sleep group compared to the other two groups, whereas there were no significant changes in the quality of life score and the attentional bias scores of the patients. Conclusions: The HARUToday Sleep app may be an effective intervention for reducing sleep problems in cancer patients. Clinical Trial: ISRCTN study ID ISRCTN11480833 http://www.isrctn.com/ISRCTN11480833